Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk.
about
Strategies to improve anxiety and depression in patients with COPD: a mental health perspectiveOverview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary diseaseA score to predict short-term risk of COPD exacerbations (SCOPEX).Pre- and post-bronchodilator airway obstruction are associated with similar clinical characteristics but different prognosis - report from a population-based study.Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.Self-reported occupational noise may be associated with prevalent chronic obstructive pulmonary disease in the us general populationEpidemiology and clinical impact of major comorbidities in patients with COPD.Anxiety and depression-Important psychological comorbidities of COPD.Is there an association between symptoms of anxiety and depression and quality of life in patients with chronic obstructive pulmonary disease?Serotonin and corticosterone rhythms in mice exposed to cigarette smoke and in patients with COPD: implication for COPD-associated neuropathogenesis.A clinical study on the role of psychosomatic therapy in evaluation and treatment of patients with chronic obstructive pulmonary disease complicated with anxiety-depression disorder.Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.Factors to inform clinicians about the end of life in severe chronic obstructive pulmonary disease.Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patientsManaging multimorbidity in primary care in patients with chronic respiratory conditions.Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathwayAssociation between prevalence of chronic obstructive pulmonary disease and health-related quality of life, South Carolina, 2011.Impact of gender on COPD expression in a real-life cohort.The impact of mood and anxiety disorders on incident hypertension at one yearRecognition, diagnosis, and treatment of cognitive and psychiatric disorders in patients with COPD.Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.Prediction and prevention of exacerbations and mortality in patients with COPD.Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression.Chronic Obstructive Pulmonary Disease Phenotypes: Implications for Care.A comprehensive analysis of association of medical history with airflow limitation: a cross-sectional study.Predictors of Change in Dyspnea Level in Acute Exacerbations of COPD.The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD.Overview of the Impact of Depression and Anxiety in Chronic Obstructive Pulmonary Disease.Risk factors associated with acute exacerbation of chronic obstructive pulmonary disease in HIV-infected and uninfected patients.Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational studyAssociations between the psychological health of patients and carers in advanced COPD.Interaction of depressive and anxiety symptoms on the mortality of patients with COPD: a preliminary study.Reply: look at the moon, not just at the finger indicating the moon.Impact of Stressful Life Events on Patients with Chronic Obstructive Pulmonary Disease.Results of a Multimodal Program During Hospitalization in Obese COPD Exacerbated Patients.Discriminant validity of the Hospital Anxiety and Depression Scale, Beck Depression Inventory (II) and Beck Anxiety Inventory to confirmed clinical diagnosis of depression and anxiety in patients with chronic obstructive pulmonary disease.
P2860
Q26765315-3C2E6DBE-DC94-4053-BAC0-FA0BA1A221E6Q27011475-CAAF0800-D184-4326-8704-82A3595A1A38Q30619543-D974E33E-6C31-4675-8EB2-078906F13683Q33627627-547C68D6-0A21-4058-A216-2B0B58093A6DQ33772323-74D55965-C194-4B2A-9829-49BF791B7C52Q33882666-7A13E9E7-B965-4DDA-834B-F411F3BB49F4Q34134841-CC4B7832-1CEE-4E50-8933-BE852FC64AD5Q34628577-5846DE17-F1BA-4297-A906-77D00D35DE79Q35073131-33C9C038-456B-449F-92D6-B9735AEC8FB2Q35092676-D70BFBDD-CFB2-4FFC-B928-FA69C94D9B97Q36318105-A64DE89A-B577-4ED0-B40A-1F723D57B66FQ36394339-085E32D3-F798-4CB5-A732-CD467BB76078Q37057081-1AD6E4D0-C380-49A2-82A8-0567970670A5Q37094676-80021E8A-3C11-40C9-8F53-3050A623FE62Q37242230-3117E21B-01ED-4CCB-A0BD-8AE7CF22FF8FQ37257970-1D79CB7A-422A-40F1-8232-D8CA87B602F5Q37405211-35D423EA-D286-4357-9CE3-88D81102AE46Q37414956-32AB4D16-728E-4162-8720-FA05AFC55AEAQ37597898-5283CAAD-258A-4A3E-AD9B-75F1D0060E00Q37615813-5685EC65-9460-4D36-9FF2-BD53A696AF65Q37652871-F3BB322D-EDEB-4EB3-A150-12F6B79AE57BQ37669183-5466F4E7-C86B-4EB1-A79C-461CCA07BF32Q38155607-E48AB5EE-5437-42EE-82BA-E5EE6C8075B9Q38203227-5525665F-AF02-4C9A-8371-C120507BAF77Q38823010-935EB8F9-DE12-41C6-A2F7-C710210B5CABQ39298699-62C35881-5209-43F0-B8FE-DB5FFFDFB712Q39422470-48087D4F-D28E-4AB6-B4E4-78782A08B9D8Q40067256-E3ADBDCF-5BA0-42BB-A234-147953471EF9Q40211649-9270D9D9-C578-4841-82DC-A5ADFA5966B4Q40319476-823D5337-8AE7-45CB-A00F-B145A491E004Q40450026-35F7EE96-378D-4468-BB97-03EAF645FBA2Q40833745-7464B137-5920-4DF6-A3E4-0AF7F95C37F2Q41073939-0B68AF06-6865-47E6-9216-CF1B20C030F4Q42196356-5CF3ADCD-A63C-44DD-AD8D-40260F351608Q42370601-D3920CC4-BEAF-4E8A-8710-52921C3A524EQ43524568-6F505B26-6F86-4AB8-B5E6-94AAC516837DQ43537483-C900D108-6F1C-43E9-B211-0ADFBB22CED4Q47572582-2EB799B5-0CC1-413F-9A3B-BA31900A3025Q47638603-01382EE4-B9C4-48FC-8DC3-26AD0FC7EE2FQ47806863-0A7061A7-6EC4-43EA-AFF4-1D905706756D
P2860
Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@en
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@nl
type
label
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@en
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@nl
prefLabel
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@en
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@nl
P2093
P1476
Impact of anxiety and depressi ...... ary disease exacerbation risk.
@en
P2093
Catherine Laurin
Grégory Moullec
Kim L Lavoie
Simon L Bacon
P304
P356
10.1164/RCCM.201105-0939PP
P407
P577
2012-01-12T00:00:00Z